Collectively, these results indicated that the presence of GCC2 on the surface of the exosomes could be a predictive marker for lung cancer diagnosis, suggesting that GCC2 could be a potential biomarker for NSCLC. The gene discussed is GCC2; the disease is lung carcinoma.